AI-Assisted Comprehensive Management for Cancer Patients With Comorbidities (GCOG-CG001)

NANot yet recruitingINTERVENTIONAL
Enrollment

5,000

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2031

Conditions
Oncological Comorbidities (e. g. Hypertension, Diabetes, Malnutrition)
Interventions
OTHER

AI-assisted comprehensive management system

Precision Risk Stratification and personalized treatment recommendation through AI models may improve the suitability of treatment regimens and thus reduce the incidence of antineoplastic therapy-related adverse effects (e.g. , reduction of chemotherapy toxicity through nutritional intervention) , and improve the efficacy of chemotherapy, and prolonged progression-free survival (PFS) and overall survival (OS)

Trial Locations (1)

453000

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang

All Listed Sponsors
lead

The First Affiliated Hospital of Xinxiang Medical College

OTHER